Oncology & Cancer

Boosting treatments for metastatic melanoma

University of Cincinnati clinician-scientist Soma Sengupta, MD, Ph.D., says that new findings from her and Daniel Pomeranz Krummel's, Ph.D., team might have identified a treatment-boosting drug to enhance effectiveness of ...

Oncology & Cancer

Scientists identify new target for melanoma immunotherapy

QIMR Berghofer research has found a new reason why some melanoma patients do not respond well to immunotherapy—a discovery that could lead to better-tailored treatments for the potentially deadly cancer.

Oncology & Cancer

Blocking tumor signals can hinder cancer's spread

For most people who die of cancer, the spread of the initial tumor is to blame. "Metastasis is what kills most cancer patients," says Serge Fuchs, a professor in Penn's School of Veterinary Medicine. "Yet there are not many, ...

Oncology & Cancer

Melanoma is killing fewest Americans in decades

Advances in treatment have led to the largest yearly declines in deaths due to melanoma ever recorded for this skin cancer, results of a new study suggest.

page 1 from 16